These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
506 related items for PubMed ID: 16823820
1. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect. Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K. Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820 [Abstract] [Full Text] [Related]
2. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K. Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491 [Abstract] [Full Text] [Related]
3. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults. Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M. Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338 [Abstract] [Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K. Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884 [Abstract] [Full Text] [Related]
5. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group. Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913 [Abstract] [Full Text] [Related]
6. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma. Isobe Y, Aritaka N, Setoguchi Y, Ito Y, Kimura H, Hamano Y, Sugimoto K, Komatsu N. J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563 [Abstract] [Full Text] [Related]
7. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood. Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T. J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409 [Abstract] [Full Text] [Related]
8. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K. Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496 [Abstract] [Full Text] [Related]
15. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. Imadome K, Shimizu N, Arai A, Miura O, Watanabe K, Nakamura H, Nonoyama S, Yamamoto K, Fujiwara S. J Infect Dis; 2005 Oct 15; 192(8):1340-8. PubMed ID: 16170750 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis. Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A. Am J Hematol; 2002 May 15; 70(1):31-8. PubMed ID: 11994979 [Abstract] [Full Text] [Related]
17. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders. Nitta Y, Iwatsuki K, Kimura H, Kojima S, Morishima T, Tsuji K, Oono T. Eur J Dermatol; 2005 May 15; 15(6):503-6. PubMed ID: 16280311 [Abstract] [Full Text] [Related]
18. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults. Rodríguez-Pinilla SM, Barrionuevo C, Garcia J, Martínez MT, Pajares R, Montes-Moreno S, Casavilca S, Montes J, Bravo F, Zaharia M, Zevallos-Giampietri E, Sanchez L, Piris MA. Am J Surg Pathol; 2010 Dec 15; 34(12):1773-82. PubMed ID: 21107082 [Abstract] [Full Text] [Related]
19. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis. Asada H, Miyagawa S, Sumikawa Y, Yamaguchi Y, Itami S, Suguri S, Harada M, Tokura Y, Ishihara S, Ohshima S, Yoshikawa K. Arch Dermatol; 2003 Dec 15; 139(12):1601-7. PubMed ID: 14676078 [Abstract] [Full Text] [Related]
20. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications. Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK. Leuk Lymphoma; 2017 Jan 15; 58(1):53-63. PubMed ID: 27157296 [Abstract] [Full Text] [Related] Page: [Next] [New Search]